Cephea South America Feasibility Study

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

NCT Number	NCT07244939
Lead Sponsor	Abbott Medical Devices
Conditions	Mitral Regurgitation, Mitral Stenosis
Enrollment	20 participants
Start Date	2025-06-17
Primary Completion	2026-09 (estimated)
Study Completion	2028-09 (estimated)
Updated on ClinicalTrials.gov	2026-02-06